Showing results (251-260 of 1,869) with videos related to
Sort By:
Pageof 187
Current Cancer Drug Targets|December 16, 2006
Modulation of the cell cycle and induction of apoptosis in human cancer cells by synthetic bile acidsNam Deuk Kim, Eunok Im, Young Hyun Yoo, et al.Current Cancer Drug Targets|June 13, 2009
Immunology of gynecologic neoplasms: analysis of the prognostic significance of the immune statusF Bellati, V Visconti, C Napoletano, et al.Current Cancer Drug Targets|September 17, 2009
Caspase-independent pathways of programmed cell death: the unraveling of new targets of cancer therapy?C Constantinou, K A Papas, A I ConstantinouCurrent Cancer Drug Targets|September 17, 2009
The PI3K/Akt/mTOR pathway as therapeutic target in neuroblastomaS FuldaCurrent Cancer Drug Targets|September 17, 2009
Sunitinib (SUTENT, SU11248) suppresses tumor growth and induces apoptosis in xenograft models of human hepatocellular carcinomaH Huynh, V C Ngo, S P Choo, et al.Current Cancer Drug Targets|June 29, 2010
New insights of CTLA-4 into its biological function in breast cancerH Mao, L Zhang, Y Yang, et al.Current Cancer Drug Targets|June 29, 2010
Wnt/β-catenin/LEF-1 signaling in chronic lymphocytic leukemia (CLL): a target for current and potential therapeutic optionsR K Gandhirajan, S J Poll-Wolbeck, I Gehrke, et al.Current Cancer Drug Targets|June 29, 2010
Paclitaxel efficacy is increased by parthenolide via nuclear factor-kappaB pathways in in vitro and in vivo human non-small cell lung cancer modelsZ W Gao, D L Zhang, C B GuoCurrent Cancer Drug Targets|June 29, 2010
The role of oxidative stress and anti-oxidant treatment in platinum-induced peripheral neurotoxicityV A Carozzi, P Marmiroli, G CavalettiCurrent Cancer Drug Targets|June 29, 2010
Oxaliplatin-mediated inhibition of survivin increases sensitivity of head and neck squamous cell carcinoma cell lines to paclitaxelZ Khan, N Khan, A K Varma, et al.Pageof 187